CellCarta Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 769

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 10

CellCarta General Information

Description

Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industries. The company operates two proprietary immune monitoring platforms that offer proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses and proteomics testing, enabling clients with a comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Contact Information

Formerly Known As
Caprion Proteomics, Caprion Proteomics GP, Caprion-HistoGeneX, Caprion Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Corporate Office
  • 201 President Kennedy Avenue
  • Suite 3900
  • Montreal, Quebec H2X 3Y7
  • Canada
+1 (514) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellCarta Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CellCarta‘s full profile, request access.

Request a free trial

CellCarta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industries. The company o
Laboratory Services (Healthcare)
Montreal, Canada
769 As of 2024
00000 0000-00-00
000000000000

000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
0000000000000
Hilden, Germany
0000 As of 0000
00000
000.00 0000-00-00
000000&0

00000

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000 000000000
Pittsburgh, PA
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CellCarta Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Qiagen Formerly VC-backed Hilden, Germany 0000 00000 000000&0
Novum Clinical Research Corporate Backed or Acquired Pittsburgh, PA 000 000000000 -
PeproTech Corporate Backed or Acquired Cranbury, NJ 00 000000&0
Adicon Clinical Laboratory Formerly PE-Backed Hangzhou, China 0000 00000 00000000 00000
Ayoxxa Biosystems Venture Capital-Backed Cologne, Germany 00 0000 000000 - 000 0000
You’re viewing 5 of 11 competitors. Get the full list »

CellCarta Patents

CellCarta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10935549-B2 Biomarkers of latent tuberculosis infection Active 14-Jul-2016 00000000000 00
US-20190277846-A1 Biomarkers of latent tuberculosis infection Active 14-Jul-2016 00000000000 0
US-10191063-B2 Brucellosis, q-fever, and lyme disease biomarkers and uses thereof Active 21-Mar-2013 00000000000 00
CA-2907023-A1 Brucellosis, q-fever, and lyme disease biomarkers and uses thereof Active 21-Mar-2013 00000000000
AU-2014233935-A1 Brucellosis, q-fever, and lyme disease biomarkers and uses thereof Inactive 21-Mar-2013 G01N33/6848
To view CellCarta’s complete patent history, request access »

CellCarta Executive Team (20)

Name Title Board Seat
Dusty Tenney Chief Executive Officer
Mark Kockx Ph.D Co-Founder & Chief Scientific Officer, Board Member and Medical Director
Lorella Di Donato Ph.D Chief Scientific Officer & Immunology and Proteomics
Christopher Ung Chief Scientific Business Officer
Hayden Routledge Ph.D Global Chief Commercial Officer
You’re viewing 5 of 20 executive team members. Get the full list »

CellCarta Board Members (13)

Name Representing Role Since
00000 0000000 Arsenal Capital Partners Chairman 000 0000
0000 00000000 00.0 CellCarta Co-Founder & Board Member 000 0000
000000 0000000 Arsenal Capital Partners Board Member 000 0000
00000 0000000 00.0 Arsenal Capital Partners Board Member 000 0000
000000 0000000 CellCarta Co-Founder & Vice Chairman 000 0000
You’re viewing 5 of 13 board members. Get the full list »

CellCarta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellCarta Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CellCarta‘s full profile, request access.

Request a free trial

CellCarta Investments (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Assays (Commercial Rights To Immuno-MRM Assays) 17-May-2022 0000000000 Buildings and Property 0000000 0
Biogazelle 14-Dec-2021 0000000000 Biotechnology 000000 00
Reveal Biosciences 11-May-2021 0000000000 Discovery Tools (Healthcare) 000000 00
Mosaic Laboratories 12-Jan-2021 0000000000 Biotechnology 000000 00
Clinical Logistics 07-Jan-2021 Buyout/LBO Medical Supplies 000000 00
You’re viewing 5 of 10 investments. Get the full list »

CellCarta Subsidiaries (3)

Company Name Industry Location Founded
Reveal Biosciences Discovery Tools (Healthcare) San Diego, CA 2012
Mosaic Laboratories Biotechnology Lake Forest, CA 0000
Histogenex Laboratory Services (Healthcare) Antwerp, Belgium 0000
To view CellCarta’s complete subsidiaries history, request access »

CellCarta FAQs

  • When was CellCarta founded?

    CellCarta was founded in 2000.

  • Who is the founder of CellCarta?

    Mark Kockx Ph.D, Martin LeBlanc, Dirk Hendriks Ph.D, and Lloyd Segal are the founders of CellCarta.

  • Who is the CEO of CellCarta?

    Dusty Tenney is the CEO of CellCarta.

  • Where is CellCarta headquartered?

    CellCarta is headquartered in Montreal, Canada.

  • What is the size of CellCarta?

    CellCarta has 769 total employees.

  • What industry is CellCarta in?

    CellCarta’s primary industry is Laboratory Services (Healthcare).

  • Is CellCarta a private or public company?

    CellCarta is a Private company.

  • What is the current valuation of CellCarta?

    The current valuation of CellCarta is 00000.

  • What is CellCarta’s current revenue?

    The current revenue for CellCarta is 00000.

  • Who are CellCarta’s investors?

    Arsenal Capital Partners has invested in CellCarta.

  • Who are CellCarta’s competitors?

    Qiagen, Novum Clinical Research, PeproTech, Adicon Clinical Laboratory, and Ayoxxa Biosystems are some of the 11 competitors of CellCarta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »